Check out market updates

Clovis Oncology applies to begin trials for targeted cancer therapy candidate

BOULDER — Clovis Oncology Inc. (Nasdaq: CLVS) has filed two Investigational New Drug applications to the U.S. Food and Drug […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *